NTRA
Natera, Inc. · Healthcare · Medical - Diagnostics & Research
Señales de momentum (gestores comparables):
amplitud de titulares +4.5% ·
flujo de acciones +0.5% ·
nuevas posiciones netas 0.0%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 215.03K | $85.48M | n/a | −3 |
| Q2 2026 | 160 | 0 | 103.68M | $28.12B | +5 | −6 |
| Q1 2026 | 164 | +3 | 98.65M | $19.54B | +6 | −4 |
| Q4 2025 | 160 | 0 | 102.31M | $23.44B | +1 | n/a |
| Q3 2025 | 23 | +1 | 81.70M | $13.15B | +1 | −1 |
| Q2 2025 | 20 | -1 | 57.32M | $9.68B | n/a | −1 |
| Q1 2025 | 18 | 0 | 31.15M | $4.40B | n/a | n/a |
| Q4 2024 | 18 | 0 | 26.97M | $4.27B | n/a | n/a |
| Q3 2024 | 17 | -1 | 21.42M | $2.72B | n/a | −1 |
| Q2 2024 | 18 | n/a | 16.29M | $1.76B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | JPMorgan Chase ✦ | 23.26M | n/a | $3.74B | 0.1% | n/c | 1 | SEC ↗ ×34 |
| 2 | The Vanguard Group ✦ (pasivo) | 12.39M | -2.3% | $1.99B | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | T. Rowe Price ✦ | 11.95M | -2.0% | $1.92B | 0.2% | ▼ Trim | 6 | SEC ↗ ×2 |
| 4 | BlackRock ✦ (pasivo) | 10.96M | +0.1% | $1.76B | 0.0% | ▲ Add | 2 | SEC ↗ ×22 |
| 5 | State Street Global Advisors ✦ (pasivo) | 3.39M | +2.2% | $545.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Duquesne Family Office ✦ | 3.21M | +4.2% | $517.44M | 13.2% | ▲ Add | 6 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasivo) | 2.60M | +1.7% | $417.63M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Wellington Management ✦ | 2.56M | -3.0% | $411.45M | 0.1% | ▼ Trim | 6 | SEC ↗ ×8 |
| 9 | AQR Capital Management ✦ | 2.40M | +39.0% | $386.34M | 0.2% | ▲ Add | 6 | SEC ↗ ×7 |
| 10 | Capital World Investors ✦ | 1.41M | +0.2% | $227.41M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | Morgan Stanley ✦ | 1.28M | n/a | $206.58M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 12 | Fidelity (FMR) ✦ | 1.11M | -23.4% | $179.22M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 13 | Goldman Sachs Group ✦ | 1.10M | n/a | $177.31M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 14 | Citadel Advisors ✦ | 896.67K | +9.2% | $144.34M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 15 | ARK Investment Management ✦ | 892.59K | -4.7% | $143.68M | 0.9% | ▼ Trim | 6 | SEC ↗ |
| 16 | Arrowstreet Capital ✦ | 558.99K | +15.7% | $89.98M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 17 | Millennium Management ✦ | 527.94K | +199.1% | $84.98M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 298.50K | -39.5% | $48.05M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 281.57K | +11.5% | $45.32M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 20 | Point72 Asset Management ✦ | 238.96K | +1.7% | $38.47M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 21 | Coatue Management ✦ | 170.33K | Nuevo | $27.42M | 0.1% | New | 1 | SEC ↗ ×7 |
| 22 | D. E. Shaw & Co. ✦ | 132.16K | -24.0% | $21.27M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 23 | Gotham Asset Management ✦ | 71.63K | -29.5% | $11.53M | 0.1% | ▼ Trim | 6 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Coatue Management | $27.42M | 0.1% |
Posición cerrada
| Norges Bank | $277.75M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 755 tenedores, 120.14M acciones, $20.15B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 627 acc. · $257,003
Director · 605 acc. · $248,847
Director · 962 acc. · $392,745
Director · 125 acc. · $51,631
Director · 211 acc. · $86,974
Director · 255 acc. · $105,995
Director · 165 acc. · $68,751
Director · 200 acc. · $81,300
Director · 80 acc. · $32,484
Director · 50 acc. · $20,258
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología